Paul Song
Directeur Général chez NKGen Biotech, Inc.
Fortune : 338 820 $ au 30/04/2024
Profil
Paul Song was the founder of Fuse Biotherapeutics, Inc. (founded in 2021) where he served as the Chief Executive Officer & Director from 2021 to 2023.
He is currently the Chairman & Chief Executive Officer at NKGen Operating Biotech, Inc., NKGen Biotech, Inc., and Mercy Corps.
Additionally, he holds the position of Director at PeproMene Bio, Inc. and Gideons Promise, Inc. Dr. Song previously worked as the Chief Medical Officer at NKMAX Co., Ltd.
(South Korea) from 2016 to 2021.
He received his undergraduate degree from The University of Chicago and his doctorate degree from George Washington University School of Medicine & Health.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,75% | 12/02/2024 | 171 121 ( 0,75% ) | 338 820 $ | 30/04/2024 |
Postes actifs de Paul Song
| Sociétés | Poste | Début |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Directeur Général | 10/01/2023 |
PeproMene Bio, Inc.
 PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Directeur/Membre du Conseil | 01/03/2022 |
Mercy Corps
 Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Directeur/Membre du Conseil | - |
| Gideons Promise, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Song
| Sociétés | Poste | Fin |
|---|---|---|
Fuse Biotherapeutics, Inc.
 Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Fondateur | 01/01/2023 |
| NKMAX CO., LTD. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Formation de Paul Song
| George Washington University School of Medicine & Health | Doctorate Degree |
| The University of Chicago | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NKMAX CO., LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
Fuse Biotherapeutics, Inc.
Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Health Technology |
PeproMene Bio, Inc.
PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Health Technology |
Mercy Corps
Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Health Services |
| Gideons Promise, Inc. |
